Eiger BioPharmaceuticals shares are scheduled to resume trading at 4:35 pm ET, with quotation set to resume at 4:30 pm ET, according to Nasdaq. Eiger BioPharmaceuticals trading was halted, news pending, ahead of the company announcing that it is discontinuing Phase 3 LIMT-2 trial of peginterferon lambda in patients with chronic hepatitis delta.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EIGR:
